Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2021.718 | The effects and cost-effectiveness of a technology-based family-centered empowerment (T-FAME) program on health and health service utilization outcomes of post-discharged patients with advanced heart failure: A sequential mixed method study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.497 | In-hospital initiation of Angiotensin–Neprilysin Inhibition for the treatment of acute heart failure regardless of ejection fraction: An open labelled randomized study | Prof. YAN Bryan Ping Yen |
| 2021.457 | Develop multi-modal spectroscopy (MMS) & biosensor platforms for monitoring cardiovascular diseases (CVDs) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.038 | Prevalence of LVEF non-recovery after acute myocardial Infarction |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.459 | BioFreedom Ultra Stent in Hong Kong All Comers Registry |
Prof YAN Bryan Ping Yen 甄秉言 |
| 2022.501 | The effect of early inpatient initiation of Dapagliflozin on the Health-related Quality of Life of patients with heart failure with all range of Ejection Fraction: a Local Registry | Prof. YAN Bryan Ping Yen |
| 2022.065 | Real World Effectiveness of Evolocumab among Chinese Patients in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2022.502 | Development of Fluorescence Probes and Nanomaterial for Plaque and Thrombosis Imaging in Patients | Prof. YAN Bryan Ping Yen |
| 2023.577 | Switching Sildenafil to Riociguat in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) | Prof. YAN Bryan Ping Yen |
| 2021.717 | In-hospital initiation of empagliflozin for the treatment of new-onset acute heart failure regardless of ejection fraction: A Pilot Study |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.164 | A Study on Outcomes of Surgical and Percutaneous Left Atrial Appendage Closure |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.335 | Evaluation of the Relationship Between Arterial Stiffness and Coronary Artery Disease by Stroke-Volume-Allocation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.162 | A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.287 | Validation of a novel device for screening patients with atrial fibrillation / arrhythmia | Prof. YAN Bryan Ping Yen |
| 2023.362 | A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.573 | Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Willingness to Follow Recommendations for Cardiovascular Prevention | Prof. YAN Bryan Ping Yen |
| 2023.194 | A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.186 | Investigation of the adverse effects of antiviral compounds |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.464 | Time-trend analysis of clinical characteristic and outcomes in patients with unprotected left main coronary artery disease treated with PCI over a 10-year period from year 2010 till year 2020. | Prof. YAN Bryan Ping Yen |
| 2022.449 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2022.409 | Validation of Pulse Sensors for Cardiovascular Disease Management |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.637 | Drug-Coated Balloon for the Treatment of De Novo and Restenotic Coronary Artery Lesion: a prospective observational study |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2023.316 | A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR™ 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2013.586 | GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) | Prof. YAN Bryan Ping Yen |
| 2013.658 | A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS | Prof. YAN Bryan Ping Yen |
| 2014.332 | A prospective Randomised, open label, blinded endpoint (PROBE) study to Evaluate DUAL antithrombotic therapy with dabigatran etexilate (110mg and 150mg b.i.d.) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with non valvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting. (RE-DUAL PCI) | Prof. YAN Bryan Ping Yen |
| 2012.481 | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome | Prof. YAN Bryan Ping Yen |
| 2014.210 | Randomized controlled trial and cost-effectiveness analysis of targeted rapid screening for atrial fibrillation using a handheld single-lead ECG device with automated diagnostics and tailored stroke prevention strategy for screen-detected patients | Prof. YAN Bryan Ping Yen |
| 2012.561 | Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Prof. YAN Bryan Ping Yen |
| 2013.420 | Transcatheter Renal Denervation with an over-the-wire balloon based technology for Patiemts with Resistant Hypertension | Prof. YAN Bryan Ping Yen |
| 2011.178 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Prof. YAN Bryan Ping Yen |
| 2013.082 | Physiologic-Guided Endovascular Revascularization for the Treatment of Atherosclerotic Erectile Dysfunction in Chinese Patients with Suboptimal Response to Pharmacotherapy: A Pilot Study | Prof. YAN Bryan Ping Yen |
| 2013.607 | Dyslipidemia International Study II (DYSIS II) | Dr Yan Bryan Ping Yen |
| 2009.543 | Patients at High Cardiovascular Risk Lack Awareness of the Importance of Risk Factor Modification and the Dire Consequences Associated with Peripheral Artery Disease : A cross sectional cohort study | Prof. YAN Bryan Ping Yen |
| 2010.123 | Cardiovascular Risk Profile & Long-term Clinical Outcomes of Patients with Peripheral Arterial Disease in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2009.542 | Impact of unrecognized peripheral arterial disease and additional prognostic value of ankle-brachial index to risk-stratify patients at high cardiovascular risk undergoing coronary angiography or intervention | Prof. YAN Bryan Ping Yen |
| 2020.332 | A Randomised, Double-Blind, Phase 1b/2a, Placebo-Controlled, Single Dose Study to Evaluate Safety, Tolerability, and Efficacy of YQ23 in Adult Patients with Critical Limb Ischaemia |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.400 | LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS treatment-Below The Knee) Randomized Controlled Trial |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.181 | Description of evolocumab use among adults with established atherosclerotic cardiovascular disease or hypercholesterolemia in Asia-Pacific region – an observational study of clinical practice |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2009.581 | In Vivo Assessment of Plaque Morphology and Vessel Injury during Percutaneous Coronary Intervention sing Intravasclar High-Resolution Optical Coherence Tmographic Imaging | Professor Yan Bryan Ping-Yen |
| 2016.687 | The effects of a modelling-based narrative intervention on care-seeking behavioural intention and prehospital care-seeking delay in patients with acute myocardial infarction | Prof. YAN Bryan Ping-Yen |
| 2012.086 | A Novel Pharmacological Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease: A Randomized Double-blind Placebo-control Trial of Traditional Chinese Medicine Salviae miltiorhizae(Danshen) and Puerariae lobatae (Gegen) | Professor Yan Bryan Ping-Yen |
| 2020.431 | Barriers and facilitators to the implementation of telemedicine-based, real-time, online consultation among family physicians working in the public sector. | Dr. YAN Chi Yung |
| 2018.632 | Comparison of the Wilson Sims Fall Risk Assessment Tool and Morse Fall Scale | Dr. YAN Connie Tin Yee |
| 2018.045 | The Prevalence of Frontotemporal Lobar Degeneration in Patients attending Psychogeriatric Services in a Local Tertiary Hospital in Hong Kong |
Dr. YAN Connie Tin Yee 甄天懿 |
| 2010.425 | RFID Traceability for Risk Management in Hospital | Prof Yan Houmin |
| 2011.288 | Perceptual and Neural Basis of Observing Sport Faking Acts | Asso. Prof Yan Jin Hong |
| 2009.559 | Separate and combining effects of fencing training and aerobic fitness on action inhibitory control in Go/Nogo Task | Asso. Prof Yan Jin Hong |
| 2011.255 | Computerized working memory training enhances motor sequence learning in young and older adults: a randomised control study. | Asso. Prof Yan Jin Hong |
| 2008.473 | A Neuropsychological and Behavioral Study of Cognitive-Motor Functioning Using a Mathematical Modeling Approach | Asso. Prof Yan Jin Hong |
Page 249 of 265.